‘Genetic signatures’ may predict prostate cancer

blood test
Researchers have identified genetic “signatures” for aggressive prostate cancer (the second most common cause of death in men, after lung cancer). The findings could one day help improve patient treatment and outcomes. These genetic patterns were identified from simple blood tests, with no tissue or biopsy was needed.
{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.